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Abstract
Metabolic homeostasis and circadian rhythms are closely intertwined biological processes. Nuclear receptors, as sensors of
hormonal and nutrient status, are actively implicated in maintaining this physiological relationship. Although the orphan
nuclear receptor estrogen-related receptor a (ERRa, NR3B1) plays a central role in the control of energy metabolism and its
expression is known to be cyclic in the liver, its role in temporal control of metabolic networks is unknown. Here we report
that ERRa directly regulates all major components of the molecular clock. ERRa-null mice also display deregulated
locomotor activity rhythms and circadian period lengths under free-running conditions, as well as altered circulating diurnal
bile acid and lipid profiles. In addition, the ERRa-null mice exhibit time-dependent hypoglycemia and hypoinsulinemia,
suggesting a role for ERRa in modulating insulin sensitivity and glucose handling during the 24-hour light/dark cycle. We
also provide evidence that the newly identified ERRa corepressor PROX1 is implicated in rhythmic control of metabolic
outputs. To help uncover the molecular basis of these phenotypes, we performed genome-wide location analyses of
binding events by ERRa, PROX1, and BMAL1, an integral component of the molecular clock. These studies revealed the
existence of transcriptional regulatory loops among ERRa, PROX1, and BMAL1, as well as extensive overlaps in their target
genes, implicating these three factors in the control of clock and metabolic gene networks in the liver. Genomic
convergence of ERRa, PROX1, and BMAL1 transcriptional activity thus identified a novel node in the molecular circuitry
controlling the daily timing of metabolic processes.
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Introduction
In most living organisms, metabolic and behavioral processes
are orchestrated in a timely fashion approximating a 24 hr daily
cycle. In mammals, light/dark (LD) cycles regulate the diurnal
activity of the master pacemaker within the suprachiasmatic nuclei
(SCN) and in turn synchronize autonomous molecular clocks in
peripheral tissues [1–3]. A small network of core clock genes
coordinate the initiation and regulation of the circadian expression
of genes and are interconnected by positive and negative
transcriptional and translational feedback loops [4]. The primary
loop is comprised of the positive transcriptional regulators BMAL1
and CLOCK and the transcriptional repressors PERIOD (PER)
and CRYPTOCHROME (CRY) [5–7]. Upon heterodimeriza-
tion, BMAL1 and CLOCK work together to activate the cyclic
expression of core clock genes and mediators of the molecular
clock called clock-controlled genes (CCGs). PER and CRY
proteins function to repress BMAL1/CLOCK transcriptional
activity to ensure the continous daily rhythmic expression of genes.
Integrity of the mammalian clock is vital as dysfunction in the
timed oscillation of genes has been associated with various diseases
including obesity and cancer [8,9].
The peripheral clock in metabolic tissues such as liver is reset by
physiological cues such as food availability [10,11] and CCG
networks are responsible for the circadian timing of metabolic
processes including glucose homeostasis, fatty acid oxidation and
cholesterol synthesis and degradation [9,12–14]. Although integral
components of the molecular clock can directly regulate some
metabolic genes, the output from the circadian oscillator is believed
to be in large part mediated through the action of transcription
factors whose patterns of expression are rhythmic in metabolic
tissues [15]. In this regard, members of the nuclear receptor
superfamily are well suited for this function. Nuclear receptors can
translate nutrient and hormone signals into specific expression
signatures of metabolic genes and several members of the family are
expressedina rhythmicfashioninmetabolictissues [16,17].Indeed,
evidence of functional cross-talk between various nuclear receptors
and core clock genes is rapidly accumulating. First, nuclear
PLoS Genetics | www.plosgenetics.org 1 June 2011 | Volume 7 | Issue 6 | e1002143receptors such as REV-ERBa and REV-ERBb (NR1D1 and
NR1D2) and RORa, b and c (NR1F1, NR1F2 and NR1F3) are
directly linked to BMAL1 and CLOCK via interconnecting positive
and negative transcriptional feedback loops [18–20]. Second,
nuclear receptors implicated in metabolic control such as PPARa
(NR1C1) and TRa (NR1A1) have been shown to act as indirect
mediators of BMAL1 and CLOCK to carry out specific metabolic
outputs in a circadian manner [21,22]. Third, PER2 has recently
been shown to propagate clock information to metabolic genes by
directly interacting with and acting as a coregulator of nuclear
receptor-mediated transcription [23].
The orphan nuclear receptor estrogen related receptor a
(ERRa, NR3B1) plays a critical role in the control of cellular
energy metabolism [24,25]. In addition, ERRa transcripts display
a diurnal rhythm in several tissues including liver, kidney, uterus
and bone [17,26,27]. The transcriptional activity of ERRa is
highly dependent on interactions with coregulatory proteins, most
notably members of the family of PGC-1 coactivator proteins
[28–32]. Interestingly, PGC-1a and PGC-1b were shown to be
rhythmically expressed in liver and skeletal muscle and PGC-1a
was shown to enhance the expression of molecular clock genes
[33]. The rhythmic expression of clock and metabolic genes were
altered in PGC-1a-null mice consequently resulting in abnormal
circadian physiological rhythms including locomotor activity, body
temperature and metabolic rate. Conversely, we have recently
shown that the metabolic function of the ERRa/PGC-1a complex
can be antagonized in liver cells by the transcriptional regulator
Prospero-related homeobox 1 (PROX1) [34]. PROX1 directly
interacts with both ERRa and PGC-1a, represses the transcrip-
tional activity of the ERRa/PGC-1a complex on metabolic gene
promoters and opposes the effects of ERRa on the respiratory
capacity of liver cells in culture. In support of these observations,
functional genomic analyses using a ChIP-on-chip approach in
mouse liver revealed that ERRa and PROX1 share approximately
50% of their target genes. These common targets include a broad
range of metabolic genes involved in carbohydrate and fatty acid
metabolism, tricarboxylic acid cycle (TCA) cycle, electron
transport and oxidative phosphorylation (OXPHOS) [34].
PROX1 has also been recently identified as a genetic locus
implicated in fasting glucose homeostasis in human subjects [35].
Whether ERRa and PROX1 participate in the rhythmic control
of metabolism and/or have functional interaction with integral
components of the molecular clock is currently unknown.
In this report, we first show that proper maintenance of diurnal
glucose, insulin, bile acid, cholesterol, non-esterified fatty acid
(NEFA) and triglyceride levels as well as locomotor rhythms in
mice is dependent on the presence of ERRa. Analyses of ChIP-on-
chip and gene expression datasets as well as functional studies
further demonstrate that ERRa PROX1 and BMAL1 are
involved in both transcriptional regulatory loops and rhythmic
control of components of all major metabolic pathways in the liver.
In particular, we show that BMAL1 directly targets a significantly
large number of genes linked to diverse biological processes,
including cellular metabolism. Our results thus demonstrate that
BMAL1 plays a more comprehensive role in the circadian output
pathways than previously anticipated and uncover a novel node in
the intricate transcriptional network necessary to sustain proper
metabolic and circadian rhythms.
Results
ERRa regulates diurnal glucose homeostasis
We have recently observed that mice lacking ERRa have
impaired diurnal blood pressure levels that are associated with
changes in the expression of Na
+ and K
+ transporters in the
kidneys [27]. These results indicate that ERRa could be involved
in orchestrating other physiological and behavioral processes in a
timely fashion. Given the importance of ERRa in the regulation of
genes involved in glycolysis and gluconeogenesis [34], we first
sought to compare blood glucose levels in wild-type (WT) and
ERRa-null mice fed ad libitum across the day. As expected [8], WT
mice display noticeable diurnal variation of glucose levels in
circulating blood (Figure 1A). However, mice lacking ERRa had
significantly lower glucose levels at Zeitgeber times (ZT) 12 and
ZT 0/24, coinciding with the start and end of the dark cycle,
respectively (Figure 1A). The observed hypoglycemia may be due
to altered glucose uptake by muscle and fat and/or glucose output
from the liver. Food availability appears to be a major determinant
in the observed differences in circulating glucose levels in ERRa-
null mice as the time-dependent hypoglycemia was lost under
fasting conditions (Figure 1B). Subsequently, we performed
glucose tolerance tests at ZT 12 and ZT 0/24 to investigate
whether differences in insulin secretion and response could
account for the deregulated glucose homeostasis observed in fed
ERRa-null mice. At ZT 12 following a 6 hr fast, basal glucose
measurements were significantly lower in ERRa-null mice but no
difference in glucose levels were seen post-glucose injection
(Figure 1C). In Figure 1D, the data is illustrated as the total area
under the curve (AUCglucose) calculated using the trapezoidal rule.
In contrast, glucose tolerance tests at ZT 0/24 revealed that
ERRa-null mice have improved glucose handling demonstrated
by significantly decreased basal blood glucose levels after a 6 hr
fast and at each subsequent time-point post-glucose administration
(Figure 1E and 1F, p=0.0046). Our data suggest that the
hypoglycemia observed in ERRa-null mice under ad libitum
feeding may in part be due to enhanced insulin secretion and/or
response. We thus measured circulating serum insulin levels and
determined however that fed ERRa-null mice have significantly
reduced insulin levels at ZT 16 (Figure 1G). The delay in insulin
secretion during the dark cycle observed in ERRa-null mice
reflects the trend towards latency in glucose uptake seen under fed
ad libitum conditions (Figure 1A and 1G). Glucose tolerance tests at
Author Summary
The molecular basis for coordinated control of circadian
rhythms and metabolism is not well understood. Although
integral components of the molecular clock such as the
transcription factor BMAL1 can directly regulate some
metabolic genes, the output from the circadian oscillator is
believed to be in large part mediated through the action
of transcription factors whose patterns of expression are
rhythmic in metabolic tissues. The estrogen-related
receptor a (ERRa, NR3B1) and its corepressor PROX1, two
major metabolic regulators, could be well suited for this
function. Indeed, we show that proper maintenance of
daily glucose, insulin, bile acid, lipid, and locomotor
rhythms in mice are dependent on the presence of ERRa.
Ablation of PROX1 in synchronized HepG2 cells revealed
the importance of PROX1 in regulating the rhythmic
expression of clock and metabolic genes. Using genome-
wide analysis of promoter occupancy and gene expression
analyses, we identify ERRa and PROX1 as novel transcrip-
tional regulators of the molecular clock and show that the
direct participation of BMAL1 in the clock output pathway
related to metabolic control is highly extensive. ERRa and
BMAL1 thus serve as key bidirectional regulators connect-
ing the peripheral clock and cellular energy metabolism.
ERRa, Peripheral Clocks, and Metabolism
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insulin levels in ERRa-null mice at this time would result in
impaired glucose tolerance. As shown in Figure 1H, loss of ERRa
expression in mice had no impact on glucose tolerance at ZT 16.
Next, we investigated whether ERRa expression is important in
maintaining the diurnal levels of other circulating metabolites. Bile
acid, total cholesterol, NEFA and triglycerides were measured in
both fed and fasted mice. ERRa-null mice were found to have
significantly greater serum bile acids at ZT 0/24 and ZT 4 under
fed and fasted conditions, respectively (Figure 2A and 2B). On the
other hand, ERRa-null mice have less circulating cholesterol,
NEFAandtriglycerides determined at leastat one time point during
a 24 hr cycle regardless of food availability (Figure 2C–2H).
Differences in these circulating metabolite levels in both fed and
fasted ERRa-null mice are more apparent when measurements
are compiled throughout a complete 12 hr light or dark cycle
(Figure 2C–2H).
We next monitored locomotor activity in WT and ERRa-null
mice. Mice in running wheel cages were first entrained in LD
conditions prior to wheel-running activity recordings over a 5 day
period. Under these light-entrained conditions, ERRa-null mice
were found to display significantly lower activity levels, ran
significantly less in the hours preceding lights off (ZT 10–12), and
presented an earlier activity offset (Table 1, Figure 3A). Subse-
quently, the mice were put in dark/dark (DD) conditions for 20
days and the recordings from day 3 to day 20 were used to define
circadian locomotor measurements in free-running conditions.
Representative actograms of WT and ERRa-null mice are shown
in Figure 3B. The ERRa-null mice were found to exhibit a free-
running period significantly shorter than that of WT mice
(23.42 hrs vs. 23.65 hrs, p=0.008) (Table 1, Figure 3C). In
addition, mice lacking ERRa displayed lower activity levels over a
24 hr period and a lower proportion of their activity in the
subjective day under DD conditions (Table 1). Overall, these
results implicate ERRa as a potential regulator of the circadian
clock.
ERRa regulates the diurnal expression of core clock and
clock-controlled genes in the liver
We have recently shown that ERRa regulates a large number of
target genes involved in a broad range of molecular functions in
the liver as determined by genome-wide ChIP-on-chip analyses
[34]. This dataset has not only reinforced the importance of ERRa
in the control of cellular metabolism but now provides evidence for
its regulation of the molecular clock. Figure 4A displays ERRa
ChIP-on-chip binding profiles on the core clock genes Arntl (known
as Bmal1), Clock, Cry1, Per2, Nr1d1 (known as Rev-erba), Nr1d2
(known as Rev-erbb), Csnk1d and Bhlhe40 (known as Dec1). Putative
ERR binding elements (ERREs) within the major binding peaks
are denoted by an asterisk (Figure 4A). ChIP-qPCR validation of
these binding events are shown in Figure 4B.
The gene encoding ERRa, Esrra, is expressed rhythmically in
the liver of ad libitum fed mice (Figure 4C). The lowest level of Esrra
expression was consistently observed at ZT 4 but we identified 2
peak levels at ZT 12 and ZT 20 whereas other groups identified
Esrra expression peaks at ZT 12–16 and ZT 16 [17,26]. The slight
variability in the peak expression times of Esrra between
laboratories may be due to differences in the housing conditions
of the mice and/or exact timing and delay in tissue isolation
between mice at the different time points. Overall, Esrra displays a
rhythmic expression pattern with trough and peak expression
levels at ZT 4 and ZT 12–20, respectively. Moreover, Esrra
expression is under the control of the circadian clock as the hepatic
rhythmic expression of Esrra under constant darkness in Clock
mutant mice is lost [26].
We next sought to investigate whether ERRa is required to
maintain the diurnal rhythm of clock gene expression in mouse
liver. As shown in Figure 4D, mice lacking ERRa have altered
diurnal rhythms of the clock genes Bma1l, Clock, Cry1 and Rev-erba.
In all cases, a difference in expression amplitude rather than a
phase-shift was observed in ERRa-null livers compared to wild-
type. The livers of ERRa-null mice express a significantly higher
level of Bmal1 between ZT 16–24, less Clock and Rev-erba levels at
ZT 8 and more Cry1 levels at ZT 20. Diurnal protein levels of
ERRa, BMAL1 and CLOCK were determined by Western blot
analysis as shown in Figure 4E. In wild-type mice, nuclear ERRa
protein levels were found to increase during the dark cycle of the
day and interestingly found to be expressed anti-phase to that of
BMAL1. Esrra mRNA expression precedes that of Bmal1 which
helps explain the observed anti-phase diurnal protein profiles of
these two factors. As expected from the mRNA profiling data,
BMAL1 protein levels are significantly increased across the day in
mouse liver lacking ERRa (Figure 4E). This result demonstrates
that ERRa activity results in strong repression of BMAL1. In
contrast, CLOCK protein levels were found to be relatively
constant throughout the day in both WT and ERRa-null livers
(Figure 4E). Our data provide evidence for ERRa as a direct
regulator of clock gene expression in mouse liver under ad libitum
feeding. Unexpectedly, Esrra, Bmal1, Clock, Cry1 and Rev-erba
expression oscillate less robustly under fasting conditions and loss
of ERRa expression alters diurnal clock gene expression to a much
lesser extent compared to that seen in fed liver (Figure 4F).
We next explored the importance of ERRa expression in
regulating the diurnal expression of genes involved in metabolism
under fed conditions as many metabolic genes are known to be
under the direct transcriptional control of the receptor [34]. First,
we examined the hepatic diurnal expression of transcriptional
regulators known to play a role in metabolic control. As shown in
Figure 5A and Figure S1A, we found altered transcript profiles of
the transcription factors Dbp, Esrrg (encoding ERRc, NR3B3),
Ppargc1a (encoding PGC-1a) and Nr0b2 (encoding SHP) in ERRa-
null mice. No significant change in expression patterns of Ppargc1b
(encoding PGC-1b), Prox1 and Nr1h4 (encoding FXR) were found
(Figure 5A and Figure S1A). In addition, the levels of the mature
form of the liver enriched ERRa microRNA target miR-122a,
involved in the regulation of cholesterol and lipid metabolism [36],
Figure 1. ERRa is involved in diurnal glucose homeostasis. Blood glucose measurements taken from fed ad libitum (A) and fasted (B) male WT
and ERRa-null mice (n=15 and n=8 for A and B respectively) at 4 hr intervals over a 24 hr period from ZT 4 to ZT 24. Error bars represent 6 SEM.
Student’s t test, *p,0.05. ZT 0 values are a duplicate of ZT 24 shown for clarity. (C) Blood glucose during a glucose tolerance test in WT and ERRa-null
mice (n=8) at ZT 12 following a 6 hr fast and intraperitoneal glucose administration of 2 mg/g body weight. Error bars represent 6 SEM. Student’s t
test, *p,0.05. (D) Area under the glucose curve at ZT 12. Error bars represent 6 SEM. (E) Blood glucose during a glucose tolerance test in WT and
ERRa-null mice (n=6) at ZT 0/24 following a 6 hr fast and intraperitoneal glucose administration of 2 mg/g body weight. Error bars represent 6 SEM.
Student’s t test, *p,0.05. (F) Area under the glucose curve at ZT 0/24. Error bars represent 6 SEM. Student’s t test, *p,0.05. (G) Diurnal serum insulin
levels in fed ad libitum WT and ERRa-null mice. Error bars represent 6 SEM. Student’s t test, *p,0.05. ZT 0 values are a duplicate of ZT 24 shown for
clarity. (H) Blood glucose during a glucose tolerance test in WT and ERRa-null mice (n=6) at ZT 16 following a 6 hr fast and intraperitoneal glucose
administration of 2 mg/g body weight. Error bars represent 6 SEM. Inset: area under the glucose curve at ZT 16. Error bars represent 6 SEM.
doi:10.1371/journal.pgen.1002143.g001
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expression in ERRa-null mice (Figure S1A). The observation that
the expression of the mature form of miR-122a and not solely the
primary transcript oscillates in liver is distinct from that of a recent
report [37], but the reason for this difference is unknown.
Furthermore, mature microRNA miR-378*, recently shown to act
as a negative regulator of the TCA cycle and oxidative metabolism
by down-regulating ERRc and GABPA expression [38] was also
found to have an altered diurnal expression in ERRa-null mice
(Figure S1A). Subsequently, we examined the rhythms of genes
involved in glycolysis/gluconeogenesis, insulin and AMPK
signaling, lipid metabolism, the TCA cycle and OXPHOS. In
ERRa-null liver, altered mRNA oscillations of the genes Pck1,
Pdha1, Pdk4, G6pc and Gck involved in glycolysis/gluconeogenesis
was observed (Figure 5B and Figure S1B). In contrast, no
significant difference in expression profiles of Slc2a2 (encoding
GLUT2), Pklr, Pcx and Pdk1 were detected. Of note, expression of
the gluconeogenic genes Pck1 and G6pc are significantly up-
regulated in ERRa-null liver at ZT 4 during the fasting phase of
the LD cycle where ERRa expression is normally at its lowest
(Figure 5B). At this time point, the transcript encoding PGC-1a,a
known activator of the gluconeogenic transcriptional program, is
also drastically increased in the absence of ERRa (Figure 5A). Our
data thus validate the previous report demonstrating that ERRa
acts as a repressor of gluconeogenesis in contrast to the overall
positive action of PGC-1a in this process [39]. Next, we analyzed
genes associated with insulin and AMPK signaling. Briefly, ERRa-
null livers express altered diurnal rhythms of the genes Gys2,
Pik3r1, Gys1, Lipe, Stk11 (encoding LKB1), Acacb (encoding ACC2)
and Mlycd with no significant change in the mRNA profiles of Insr,
Pik3c2g and Prkag2 (Figure 5C). In Figure 5D, we demonstrate that
the diurnal expression patterns of genes involved in fatty acid,
cholesterol and bile acid metabolism are dependent on ERRa.
Specifically, Acadm, encoding the enzyme MCAD important in
fatty acid b-oxidation [40] and Hmgcr, encoding the rate-limiting
enzyme HMG-CoA reductase in cholesterol biosynthesis [41] are
up-regulated in ERRa-null mice at specific times during the day.
Despite the increased expression of Hmgcr found in the liver,
ERRa-null mice have reduced circulating levels of cholesterol
during the light phase of the day as shown earlier. Moreover,
hepatic genes involved in bile acid biosynthesis and transport
Cyp7a1, Cyp8b1 and Abcb11 (encoding BSEP) respectively, are
generally down-regulated in the absence of ERRa (Figure 5D).
Consequently, decreased circulating bile acids would be antici-
pated in ERRa-null mice but, as described above, we found
increased levels at ZT 0/24. Reduced Cyp7a1 and Cyp8b1 gene
expression in ERRa-null liver may be attributable to possible
negative feedback inhibition exerted by the higher bile acid levels
but the exact mechanism is unknown. The expression profiles of
genes associated with mitochondrial energy production were also
explored. Overall, we found a significant reduction in the
expression profiles across a 24 hr cycle of many TCA cycle and
OXPHOS genes including Cs, Aco2, Sdhd, Cycs, and Ndufb5 in
ERRa-null liver (Figure S1C). Taken together, our data clearly
defines ERRa as an important player in the diurnal regulation of
clock gene expression and of many metabolic genes involved in
Table 1. Circadian phenotypic characterization of ERRa-null mice.
Characteristic WT (n=9) ERRa-null (n=10) p-value Student’s t test
Activity levels
LD: wheel counts/24 hrs 26995±1759 18206±919 0.0002
DD: wheel counts/24 hrs 27360±2879 21759±2188 0.018
% activity (ZT 0–12) 5.861.2 3.561.1 0.164
% activity between ZT 10–12 1.1±0.5 0.1±0.1 0.032
% activity (CT 0–12) 17.2±2.4 9.2±2.0 0.012
% activity between CT 10–12 5.061.7 4.261.2 0.892
Phase of activity in LD
Phase activity onset (ZT 12, min)
1 0.063.0 4.860.6 0.064
Phase activity offset (ZT 0, min)
1 25.2±7.8 225.8±10.8 0.0014
Running bouts
Average bout length (min) 169.7613.5 162.5613.1 0.688
Average counts/bout 7224±814 5066±431 0.021
Average peak speed (rotations/min) 50.462.1 52.261.9 0.507
Bouts/day 4.360.7 3.760.2 0.320
Circadian behavior
Endogenous period (hrs) 23.65±0.06 23.42±0.04 0.008
Results in bold are statistically different between WT and ERRa-null mice.
1Phase angle relative to lights off (ZT 12) for activity onset and relative to lights on (ZT 0) for activity offset.
doi:10.1371/journal.pgen.1002143.t001
Figure 2. Diurnal variation of serum bile acid, cholesterol, NEFA, and triglyceride levels in WT and ERRa-null mice. Circulating
metabolic parameters were measured in fed ad libitum and fasted WT and ERRa-null mice (n=4) at 4 hrs intervals over a 24 hr period from ZT 4 to ZT
24. Error bars represent 6 SEM. Student’s t test, *p,0.05 at individual time points or across a 12 hr light or dark cycle. ZT 0 values are a duplicate of
ZT 24 shown for clarity. (A–B) Fed and fasted bile acid, (C–D) fed and fasted total cholesterol, (E–F) fed and fasted NEFA and (G–H) fed and fasted
triglyceride levels are shown.
doi:10.1371/journal.pgen.1002143.g002
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several metabolic genes that are not known to be direct targets of
ERRa were altered in the liver including Esrrg, Ppargc1a and
Cyp7a1. Our data suggest that ERRa participation in the mainte-
nance of cyclic gene expression is mediated by direct and indirect
transcriptional control of genes via regulation of the molecular
clock and other transcriptional regulators.
Genomic convergence between BMAL1/CLOCK and ERRa
in the transcriptional control of metabolic genes
We next sought to determine the extent of the functional
relationship between BMAL1 and ERRa in the direct control of
metabolic gene networks. To this end, we first performed a mouse
liver BMAL1 ChIP-on-chip experiment using tiled arrays covering
extended promoter regions (25.5 to +2.5 kb from transcriptional
start sites) of ,17,000 genes, the same platform previously used to
identify ERRa occupancy in the genome of mouse livers taken at
ZT 4 in LD conditions [34]. We identified 2,555 high-confidence
BMAL1 binding sites mapping to the promoter regions of 2,522
genes (Table S1). First, we classified the target genes associated
with a known function into general cellular functional categories as
shown in Figure 6A. BMAL1 was found significantly enriched at
promoters of genes involved in a broad range of metabolic
processes, including amino acid, lipid, carbohydrate and TCA
cycle/OXPHOS. In addition, ,15% of the BMAL1 target genes
are involved in transcriptional regulation, including genes
encoding numerous transcription factors, nuclear receptors
involved in metabolic control (see below), splicing factors and
polymerases. De novo motif discovery using MDscan [42] analysis
of enriched binding segments revealed the expected consensus E-
box motif, CACGTG (Figure 6A). BMAL1 enrichment at the
extended promoter regions of core clock genes including Cry2,
Dbp, Dec1, Dec2, Per1, Per2, Per3 and Rev-erba further validates the
approach using extended promoter arrays (Figure 6B and Figure
S2). Furthermore, our analysis revealed previously unidentified
binding sites for BMAL1/CLOCK within the promoters of Bmal1
and Clock themselves as well as in the Csnk1d promoter (Figure 6B
and Figure S2). Cry1, a known BMAL1/CLOCK target gene,
missed the ChIP-on-chip p-value cutoff but did validate in
standard BMAL1 and CLOCK ChIP-qPCR experiments along
with other tested target genes (Figure 6C). Our data not only
shows that BMAL1/CLOCK can directly bind to the core clock
genes but that they can also directly bind to their own promoters,
thus identifying a previously unrecognized autoregulatory loop.
We next compared the overlap in target genes between ERRa
and BMAL1 in mouse liver. As shown in Figure 6D, comparison of
the datasets revealed that a total of 891 target genes are shared by
both factors (37.5% of all ERRa targets). A significant number of
common targets, which include Pck1, Hmgcr, Nr0b2 and miR-122a,
were found to have altered cyclic expression patterns in ERRa-null
mice (Figure 5 and Figure S1), amplifying the importance of ERRa
as a transcriptional regulator of clock-controlled genes. We next
identified significantly enriched biological pathways associated with
target genes that are specific to ERRa, BMAL1 or both factors. A
subset of the analysis is shown in Figure 6E. ERRa-specific targets
were highly enriched in metabolic and energy producing processes
including inositol metabolism, lipid metabolism, the TCA cycle,
ubiquinone biosynthesis and OXPHOS. Targets shared by ERRa
and BMAL1 were also associated with metabolic processes such as
AMPK and insulin receptor signaling in addition to glycolysis/
gluconeogenesis. ChIP qPCR validation of ERRa and BMAL1
enrichment at the promoters of several genes involved in these
processes including Stk11, Prkag2, Insr, Pik3c2g, Gys2 and G6pc is
shown in Figure S3. Moreover, there was a strong enrichment of
common ERRa and BMAL1 target genes involved in immune
response as well as in circadian rhythm signaling (Figure 6E).
Targets specific to BMAL1 were enriched in a wide variety of
processes associated with protein assembly, nucleic acid metabolism
as well as renin-angiotensin, hormone and cancer signaling
(Figure 6E). In order to execute clock-controlled physiological and
behavioral processes in a timely and efficient manner, BMAL1/
CLOCK regulate a number of factors involved in transcription to
mediate clock outputs. As we previously noted, BMAL1 was found
to be enriched at over 300 target genes associated with
transcriptional regulation including genes encoding the nuclear
receptors ERRa, COUP-TFII (NR2F2), GCNF (NR6A1), HNF4a
(NR2A1), LRH-1 (NR5A2), PPARa PPARc (NR1C3), PXR
(NR1I2), SHP (NR0B2), REV-ERBa, RORc, RXRb (NR2B2),
Figure 3. Altered locomotor activity in ERRa-null mice. (A) Locomotor activity profiles for WT and ERRa-null mice (n=9–10) maintained in LD
conditions in running wheel cages. (B) Representative actograms of one WT and one ERRa-null mouse first entrained in LD conditions and then kept
in constant darkness (DD) for 3 weeks in running wheel cages. Grey zones represent darkness. (C) Bar graph representing the endogenous period
lengths of WT (n=9) and ERRa-null mice (n=10) in constant darkness. Error bars represent 6 SEM. Student’s t test, *p=0.008.
doi:10.1371/journal.pgen.1002143.g003
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PLoS Genetics | www.plosgenetics.org 7 June 2011 | Volume 7 | Issue 6 | e1002143Figure 4. ERRa binds to and regulates core clock gene expression. (A) Binding profiles of ERRa on the extended promoters of core clock
genes in mouse liver. Putative ERRa binding sequences (ERREs) are shown on the major binding peaks indicated with an asterisk. (B) Standard ChIP
validation reveals that ERRa is enriched at molecular clock target genes using primers amplifying the identified binding peaks in A. (C–D) Male WT
and ERRa-null mice (n=4) kept in LD conditions were sacrificed at 4 hr intervals over a 24 hr period from ZT 4 to ZT 24. Circadian qRT-PCR analysis of
Esrra (C) and molecular clock components (D) were performed on RNA isolated from mouse livers and relative expression data normalized to Arbp
levels are shown as a function of ZT. Data shown are relative to WT expression levels at ZT 4 arbitrarily set to 1. ZT 0 values are a duplicate of ZT 24
shown for clarity. Error bars represent 6 SEM. Student’s t test was used to compare WT and ERRa KO liver expression data at the indicated time
points, *p,0.05. (E) Western blot analysis of diurnal WT and ERRa-null mouse liver nuclear lysates. Protein extracts from 4 mice at each of the
indicated time points were pooled and immunoblotted for ERRa, BMAL1 and CLOCK. (F) Male WT and ERRa-null mice (n=4) kept in LD conditions
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HIF1a, IRF8, GABPA, and STAT3, and the transcriptional
coregulators PGC-1a, PGC-1b, NCoR1 and PROX1. In addition,
the microRNAs miR-17, -22, -101a, -122a, -200c and let-7c-2
were also identified as BMAL1 targets. BMAL1/CLOCK ChIP
validation of a subset of these genes is shown in Figure 6F. In
particular, our data show that ERRa is indeed a direct downstream
target of BMAL1/CLOCK. Figure 6G displays the binding profile
of BMAL1 on the mouse Esrra promoter with close examination of
the DNA sequence under the peak. We identified a BMAL1/
CLOCK consensus E-box binding motif (CACGTG) located
adjacent to the well characterized, duplicated ERR binding sites
(TNAAGGTCA) [29] that is conserved in mouse and human
(Figure 6G). Luciferase reporter assays in COS-1 cells show that
BMAL1 alone induces the activity of the Esrra promoter which was
further enhanced in the presence of PGC-1a (Figure 6H).
Prox1 expression is rhythmic and regulates clock gene
expression
Prox1 is a direct BMAL1/CLOCK target gene (Figure 6F) and
consequently, we next sought to examine if Prox1 expression, like
that of other components of the ERRPGC-1 transcriptional
pathway, is rhythmic in mouse liver. Wild-type and Clock mutant
mice kept in constant darkness were used to measure the circadian
expression of Prox1. As expected, Rev-erba was found to have an
expression peak at circadian time (CT) 6 and the mRNA
oscillation was abrogated in Clock mutant mice (Figure 7A, top
panel). Interestingly, we observed a cyclic expression in Prox1
transcript levels with two expression peaks at CT 10 and CT 18
that was abolished in Clock-mutant mice under DD conditions
(Figure 7A, bottom panel). Unlike in constant darkness, Prox1
oscillates with one expression peak during the night in light-
entrained conditions as shown earlier (Figure 5A) suggesting that
Prox1 expression is influenced by light. Taken together, our data
indicate that Prox1 expression is rhythmic and under direct control
of the molecular clock.
We next sought to determine if PROX1 was also involved in a
regulatory loop with BMAL1/CLOCK. Indeed, ChIP-on-chip
experiments revealed PROX1 recruitment to the clock target
genes Bmal1, Clock, Cry1, Cry2, Csnk1d, Dec1, Per1, Rev-erba and
Rev-erbb as shown in Figure 7B. ChIP-qPCR validation of these
binding events are shown in Figure 7C. We next wanted to
investigate PROX1 regulation of the molecular clock. Unlike
ERRa-null mice, PROX1-deficient mice are embryonic lethal and
die at embryonic day E14.5-E15 [43]. Consequently, we used the
HepG2 liver cell line to analyze the expression of direct clock
target genes in the presence or absence of siRNA pools targeting
PROX1. Ablation of PROX1 in HepG2 cells resulted in an
increase in Bmal1, Clock, Cry2 and Dec1 expression as well as a
decrease in Csnk1d, Rev-erba and Rev-erbb levels (Figure 7D).
Subsequently, serum shock was used to synchronize clock gene
oscillation in HepG2 cells to determine the effects of loss of
PROX1 on the rhythmic expression of these genes. qRT-PCR
analysis of clock gene expression over a 24 hr period was studied.
Overall, ablation of PROX1 in synchronized HepG2 cells resulted
in significantly altered oscillations and abundances of clock
transcripts (Figure S4A). Our data show that PROX1 is a
regulator of the molecular clock by acting as either an activator or
repressor of clock gene expression. Moreover, we observed altered
expression rhythms of Pck1, Slc2a2 and Aldoc involved in glucose
homeostasis in the absence of PROX1 in synchronized HepG2
cells (Figure S4B). As a whole, PROX1 can function both as an
upstream clock regulator and direct downstream mediator of clock
function. A schematic representation of the integration of ERRa
and PROX1 as well as BMAL1 in transcriptional control of
mammalian clock components is shown in Figure 7E.
Convergence of ERRa, PROX1, and BMAL1 target genes
integrates the molecular clock with metabolism
Analysis of the gene networks commonly regulated by ERRa,
PROX1 and/or BMAL1 shows that 905 (,35.8% of all BMAL1
targets) target genes are common to PROX1 and BMAL1 and that
891 (,35.3% of all BMAL1 targets) target genes are shared by
ERRa and BMAL1 (Figure 8A and Table S2). Overall, 512 targets
are shared by all 3 factors (,20% of all 3 datasets), indicating a
significant level of coordination in the control of specific gene
networks. Comparative analysis of these datasets with mouse liver
circadian expression data compiled from five different experiments
performed with mice under basal conditions maintained in constant
darkness [12,44–47] indicates that a large subset of ERRa, BMAL1
and PROX1 target genes displays rhythmic expression in the liver
(Figure S5 and Table S3). A gene found to be rhythmic in at least
one dataset was considered in our analysis. Interestingly, we also
observed that genes commonly targeted by either BMAL1 and
ERRa, BMAL1 and PROX1 or by all three factors are enriched for
metabolic genes (e.g. fatty acid and carbohydrate metabolism) as
compared to genes targeted by BMAL1 alone (Figure 8B). A
schematic representation of the metabolic and nutrient sensing
pathways targeted by BMAL1 alone or in combination with ERRa
and PROX1 is shown in Figure 8C.
Discussion
In this study we first identified ERRa, an orphan nuclear
receptor known to play a central role in the control of energy
homeostasis, as an important regulator of the mammalian
circadian clock and its output pathways at both transcriptional
and physiological levels. Indeed, we have shown that ERRa
occupies the promoter region of several core clock genes and that
Esrra is itself a direct transcriptional target of BMAL1/CLOCK.
While control of the expression of transcription factors involved in
metabolic homeostasis provides a sensible molecular mechanism
linking core clock genes and metabolism, our results also revealed
that BMAL1 directly targets an unexpectedly large number of
genes associated with a wide-array of biological processes,
including cellular metabolism. In fact, the extensive transcriptional
crosstalk between ERRa, BMAL1 and the metabolic coregulator
PROX1 firmly positions these three factors at the center of the
coordinated control of circadian rhythms and cellular metabolism
(Figure 8C).
ERRa, a regulator of diurnal metabolic homeostasis
As a direct target of BMAL1/CLOCK and a major regulator of
energy metabolism, ERRa may also play a central role in clock-
controlled output pathways linked to metabolic homeostasis.
Indeed, the importance of ERRa as an integrator of the molecular
were sacrificed at 4 hr intervals over a 24 hr period from ZT 4 to ZT 24 following a 24 hr fast. Circadian qRT-PCR analysis of Esrra and molecular clock
components were performed on RNA isolated from mouse livers and relative expression data normalized to Arbp levels are shown as a function of ZT.
Data shown are relative to WT expression levels at ZT 4 arbitrarily set to 1. ZT 0 values are a duplicate of ZT 24 shown for clarity. Error bars represent
6 SEM. Student’s t test was used to compare WT and ERRa KO fasted liver expression data at the indicated time points, *p,0.05.
doi:10.1371/journal.pgen.1002143.g004
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mice results in altered hepatic diurnal expression rhythms of genes
associated with diverse metabolic processes, the majority of which
are known to display circadian rhythms (e.g. Cyp7a1, Hmgcr, Pck1,
Pdk4, PGC-1a and Stk11). In this context, the finding of the potential
regulation of Per2 by ERRa is also particularly interesting. PER2
has recently been shown to interact with several nuclear receptors
and serve as a coregulator of nuclear receptor-mediated transcrip-
tion and it has thus been proposed that PER2 could confer more
precise oscillator information to metabolic genes [23]. Given that
ERRa has been shown to occupy the regulatory region of genes
encoding a plethora of nuclear receptors that includes the PER2
partners HNF4a, PPARa and REV-ERBa [34], ERRa could serve
as an amplifier of the PER2-dependent clock output.
Diurnal serum chemistry profiling revealed an important role of
ERRa in maintaining metabolic homeostasis. Altered diurnal
glucose, insulin, bile acid, cholesterol, NEFA and triglyceride levels
were observed in ERRa-null mice. Of particular interest, fed
ERRa-null mice exhibit time-dependent hypoglycemia and hypo-
insulinemia with no apparent impairment in insulin secretion as
determined by glucose tolerance tests. We thus hypothesize that the
observed hypoglycemia in ERRa-null mice is a result of enhanced
glucose uptake due to increased insulin sensitivity. In complete
agreement with our findings in ERRa-null mice, a report published
duringpreparationof this manuscript showedthat administration of
a novel highly selective ERRa inverse agonist (compound 29) in
diet-induced murine models of obesity and an overt diabetic rat
model resulted in improved insulin sensitivity and glucose tolerance
accompanied by reduced circulating glucose, free fatty acid and
triglyceride levels [48].
ERRa, a novel direct regulator of the circadian clock
Nuclear receptors have been previously implicated as compo-
nents of the output pathways of the molecular clock but their
involvement in these processes has usually been inferred through
the regulation of one to a few specific genes [22]. Previous in situ
hybridization experiments revealed that 19 of 49 nuclear receptors
are expressed in the mouse SCN [49]. However, lack of apparent
expression of any ERR isoform in the SCN suggests that the ERRs
are not critically involved in SCN physiology and clock
entrainment. This is supported by the modest change in free-
running period of locomotor activity rhythms (Figure 3). Instead,
ERRs may act as regulators of clock function in peripheral tissues.
Indeed, this study demonstrates that ERRa plays a key role in
hepatic regulation of the molecular clock.
We show that ERRa, as a regulator of the core clock
mechanism, targets the promoter region of many core clock
genes, including Bmal1, Clock, Cry1, Per2, Rev-erba and Rev-erbb and
that the presence of ERRa is necessary to maintain the diurnal
rhythm of many of these genes in the liver. Of particular interest,
ERRa was found to display very potent repressor activity on
BMAL1 (Figure 4D and 4E). Unlike the nuclear receptor REV-
ERBa that couples the positive and negative limbs of the
molecular oscillator, the role of ERRa in the clock is more likely
to contribute to the robustness of circadian oscillation in response
to specific physiological cues. In this context, physiological
rhythms dependent on ERRa transcriptional activity is expected
to be modulated via changes in the levels of PGC-1a in response to
nutritional signals [33], and/or the activity of the SIRT1 histone
deacetylase complex which is known to act as an intracellular
metabolic sensor and a post-translational modifier of both PGC-1a
and ERRa [50,51]. This is particularly relevant in regard to the
superimposed metabolic and circadian clock feedback loops
involving interplay between the rhythmic NAD
+ biosynthesis,
SIRT1, and CLOCK/BMAL1 [52,53].
A direct role for BMAL1 in liver metabolism
BMAL1 is an important regulator of metabolism. In particular,
liver-specific disruption of Bmal1 in mice results in hypoglycemia,
higher glucose clearance and loss of rhythmic expression of clock-
regulated metabolic genes, highlighting the importance of the
peripheral oscillators in modulating circadian physiology [14,52].
Our BMAL1 ChIP-on-chip study in mouse liver indicates that
BMAL1 plays a more comprehensive role in dictating metabolic
clock outputs. We find that BMAL1 binding sites are particularly
enriched in genes involved in amino acid (e.g. Got1, mTor), lipid (e.g.
Acadm, Lipe) and carbohydrate (e.g. G6pc, Insr) metabolism as well as
in the TCA cycle/OXPHOS (e.g. Cs, Atp5g) (Figure 8C and Table
S1). Of particular interest is the finding that BMAL1 binds to two
distinct sites within the promoter of Slc2a2, which encodes glucose
transporter type 2 (GLUT2). This finding thus provides a molecular
mechanism for the loss of rhythmic expression of Slc2a2 in liver-
specific BMAL1-deficient mice which has been proposed to account
for the observed circadian hypoglycemia in these mutant mice [14].
More globally however, our study demonstrates that direct BMAL1
target genes are not exclusively associated with metabolism but with
a large set of diverse biological functions. This finding is in
agreement with previous expression studies showing that temporal
hepatic gene regulation is extensive and impinges on a wide variety
of processes [12,45,46]. Our work suggests that the extensive
identification of BMAL1 target genes supports a more direct
participation of core clock proteins in driving clock output
pathways.
Prox1, a novel regulator of the molecular clock and
metabolism
Our study provides evidence for a direct participation of
PROX1 in transcriptional regulation of the molecular clock. In
particular, clock gene synchronization in HepG2 cells revealed
that ablation of PROX1 results in altered oscillation of core clock
genes. In this context, we also show that PROX1 is required to
maintain the rhythmic expression of genes involved in glucose
homeostasis. Taken together with the recent identification of
PROX1 as an important regulator of the ERRa/PGC-1a axis
involved in the regulation of broad transcriptional programs
implicated in the control of energy homeostasis in the liver [34]
and the observation that the PROX1 locus is associated with
fasting glucose levels and increased risk for type II diabetes [35],
this study implies that PROX1 possesses all the necessary
attributes to be an important factor linking metabolism and
circadian rhythms.
Figure 5. ERRa is necessary to maintain the rhythmic expression of metabolic genes. Circadian expression of genes involved in
transcriptional regulation (A), glycolysis/gluconeogesesis (B), insulin and AMPK signaling (C) as well as in lipid metabolism (D) are shown. Male WT
and ERRa-null mice (n=4) kept in LD conditions were sacrificed at 4 hr intervals over a 24 hr period from ZT 4 to ZT 24. qRT-PCR analysis was
performed on RNA isolated from mouse livers and relative expression data normalized to Arbp levels are shown as a function of ZT. Data shown are
relative to WT expression levels at ZT 4 arbitrarily set to 1. ZT 0 values are a duplicate of ZT 24 shown for clarity. Error bars represent 6 SEM. Student’s
t test was used to compare WT and ERRa KO liver expression data at the indicated time points, *p,0.05.
doi:10.1371/journal.pgen.1002143.g005
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PLoS Genetics | www.plosgenetics.org 11 June 2011 | Volume 7 | Issue 6 | e1002143Figure 6. BMAL1/CLOCK regulation of the ERRa promoter. (A) Pie chart representing the major cellular functions associated with BMAL1
targets enriched in the adult mouse liver using extended promoter arrays. Motif finding algorithm, MDscan, showed that the sequence CACGTG
corresponding to the consensus BMAL1/CLOCK E-box binding motif is the most abundant motif present in the first 200 BMAL1 bound segments used
in the analysis. (B) Binding profiles of BMAL1 on extended promoters of a subset of core clock gene targets obtained from ChIP-on-chip. Putative
BMAL1/CLOCK binding sequences (E-boxes) found, if any, at the binding peaks validated indicated with an asterisk are shown. (C) BMAL1/CLOCK
standard ChIP assay in mouse liver on the core clock genes shown in B. (D) Venn Diagram illustrating the overlap in ERRa and BMAL1 direct targets
obtained from ChIP-on-chip analyses in mouse liver. (E) Enrichment of a subset of canonical pathways in the ChIP-on-chip target genes determined to
be common (yellow) or specific to either ERRa (pink) or BMAL1 (blue). Grey line indicates the p-value threshold cutoff of 0.05. *p,0.05. (F) BMAL1/
CLOCK standard ChIP assay in mouse liver on genes associated with transcriptional regulation including ERRa. (G) Schematic representation of a
fragment of the mouse, rat and human ERRa promoter showing a conserved BMAL1/CLOCK E-box consensus binding motif, CACGTG, adjacent to the
conserved ERRa binding element, TGAAGGTCA. (H) Reporter gene assays in COS-1 cells using a mouse Esrra promoter luciferase reporter construct in
the presence of either empty vector, ERRa, CLOCK, BMAL1 or combinations of in the presence or absence of PGC-1a. Luciferase activity was assayed
24 hrs post-transfection and the relative luciferase units (RLU) shown are the mean of duplicate assays.
doi:10.1371/journal.pgen.1002143.g006
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PLoS Genetics | www.plosgenetics.org 12 June 2011 | Volume 7 | Issue 6 | e1002143Figure 7. PROX1 is a regulator of the molecular clock that itself exhibits a rhythmic clock-dependent circadian expression. (A) Male
WT and Clock mutant mice (n=4) kept in DD conditions were sacrificed every 4 hrs over a 24 hr period from circadian time (CT) 2 to CT 22. qRT-PCR
analysis was performed on RNA isolated from mouse livers and relative expression data normalized to Arbp levels are shown as a function of CT. Error
bars represent 6 SEM. (B) Binding profiles of PROX1 on the extended promoters of core clock genes generated from a recently published ChIP-on-
chip experiment in mouse liver. (C) Standard ChIP validation of molecular clock genes identified as direct target genes of PROX1. (D) qRT-PCR was
performed on RNA isolated from HepG2 cells treated with control siRNA or an siRNA Dharmacon On-Target Smartpool against PROX1. The expression
of molecular clock genes was determined and the data is shown as relative fold expression levels compared to control siRNA and normalized to
HPRT1 levels. Data represent mean 6 s.d. of triplicate independent experiments. Student’s t test, *p,0.05. Western blot analysis on lysates prepared
from the HepG2 knockdown samples is shown with the respective antibodies as indicated. (E) Schematic showing the transcriptional crosstalk
between ERRa, PROX1 and BMAL1 on molecular clock genes as well as Esrra and Prox1. Genes found to be direct targets of ERRa, PROX1 and/or
BMAL1 are indicated by arrows.
doi:10.1371/journal.pgen.1002143.g007
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rhythmic control of metabolic genes
We have shown that BMAL1 targets the promoter region of a
substantial number of metabolic genes. However, a comparative
analysis of BMAL1, ERRa and PROX1 targets indicates that the
presence of BMAL1 alone is insufficient to regulate the expression
of metabolic gene networks (Figure 8B and 8C and Table S2). In
contrast, these results suggest that the regulation of metabolic
genes involves coordinated action by the three factors. Whether
BMAL1 can directly interact with ERRa and/or PROX1 is
currently unknown. We suggest that ERRa may function by
contributing to the robustness of the rhythmic expression of
BMAL1 target genes. Similarly, the overlap between BMAL1 and
PROX1 target genes, especially those not shared by ERRa,
probably denotes the presence and action of other partners of
PROX1 such as the metabolic regulators HNF-4a and LRH-1
[54,55]. The physiological significance of the functional interac-
tion between these factors is further supported by the observation
that a considerable subset of ERRa/BMAL1/PROX1 target
genes displays circadian expression in the liver (Figure S5 and
Table S3). Finally, as ERRa expression is regulated by metabolic
cues, we can anticipate that the rhythmic expression of ERRa and
many of its target genes will be driven by both feeding and the
clock.
Summary
We have identified the orphan nuclear receptor ERRa as a novel
transcriptional regulator of both the molecular clock and its output
pathways that shares extensive transcriptional cross-talk with the
core clock protein BMAL1. As such and given the known property
of ERRa to translate signals propagated by physiological sensors
such as PGC-1a and SIRT1 into metabolic gene expression
networks, ERRa may serve as the key bidirectional regulator
connecting the peripheral liver clock and cellular energy metabo-
lism. Similarly, we show that the ERRa corepressor PROX1 can
act both upstream and downstream of the endogenous clock.
Furthermore, our study showed that the direct participation of
BMAL1 in the clock output pathways is highly extensive, suggesting
that other core clock proteins might play a similar role. Therefore,
additional investigations of the functional relationship between
ERRa, PROX1 and core clock genes in diverse tissues are bound to
reveal other key molecular mechanisms and physiological pheno-
types linked to the daily timing of biological processes.
Materials and Methods
Ethics statement
Animal use followed the guidelines of the Canadian Council
on Animal Care. The animal use protocol was approved by the
Figure 8. ERRa, PROX1, and BMAL1 genomic convergence linking the clock with metabolism. (A) Venn Diagram illustrating the overlap in
ERRa, PROX1 and BMAL1 direct targets obtained from ChIP-on-chip analyses in mouse liver. (B) Comparison between the functionally enriched
biological processes associated with BMAL1 targets shared by ERRa and/or Prox1 or bound by BMAL1 only. Target genes specific for BMAL1
association with ERRa and/or Prox1 were enriched for metabolic processes where targets specific to BMAL1 alone were enriched for processes related
to chromatin structure and cell cycle. *p,0.01. (C) Schematic representing target genes specific to BMAL1 (blue) or those shared by BMAL1/ERRa
(pink), BMAL1/PROX1 (purple) or BMAL1/ERRa/PROX1 (green) associated with diverse metabolic processes.
doi:10.1371/journal.pgen.1002143.g008
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University.
Animals
Male wild-type and ERRa-null mice [56] 2–3 months old in a
C57BL/6J genetic background were housed and fed standard
chow in the animal facility at McGill University Life Sciences
Complex. Mice were entrained to a 12 hr light/12 hr dark LD
cycle for 2 weeks prior to the start of the experiment. Animals were
sacrificed by cervical dislocation at 4 hr intervals over a 24 hr
period from ZT 4 to ZT 24 (n=4 per ZT). ZT 0 is the time of
lights on, ZT 12 is the time of lights off. Livers were isolated,
frozen in liquid nitrogen and grinded using a mortar and pestle
and kept frozen until further processing. Male wild-type and Clock
mutant mice [57] 2–3 months old in a 50% C57BL/6J and 50%
BALB/c genetic background were housed and fed standard chow
in the animal facility at the Douglas Mental Health University
Institute. For circadian experiments, livers from 4 WT and Clock
mutant mice kept in DD conditions were collected every 4 hrs
from circadian time (CT) 2 to CT 22 and immediately frozen in
liquid nitrogen until further processing.
ChIP, ChIP-on-chip, ChIP-qPCR, and functional analysis of
target genes
ERRa and PROX1 ChIP assays were performed as previously
described [34,58] on adult male mouse livers at ZT 4. For BMAL1
and CLOCK ChIP assays, chromatin corresponding to 0.4 g of
initial liver mass taken from a pool of 44 livers at ZT 4 was used and
pre-cleared chromatin was immunoprecipitated with 6 mgo fa n
anti-BMAL1 antibody (Santa Cruz, sc-48790x), 6 mg of an anti-
CLOCK antibody (Santa Cruz, sc-25361x) or not (no antibody
control) with subsequent addition of 50 ml of a 50% slurry of salmon
sperm DNA/protein A beads for 3 hrs at 4uC. To assess the
enrichment of ERRa, PROX1, BMAL1 or CLOCK at specific
promoters, quantitative PCR (qPCR) was performed as described
previously [58]. Enrichment of DNA fragments was normalized
against two amplified regions using the control primers, located
approximately 4 kb upstream of the ERRa and 49 kb upstream of
the PROX1 transcriptional start site. Specific mouse primers
designed and used for ChIP-qPCR analysis are shown in Tables S4
and S5.
Duplicate mouse liver BMAL1 ChIP-on-chip experiments using
tiled extended promoter arrays covering 25.5 to +2.5 kb from
transcriptional start sites of ,17,000 genes (mm8) from Agilent
were performed as previously described [34,58] with the following
modifications. Chromatin corresponding to 3.1 g of initial liver
mass taken from a pool of 44 livers was used and pre-cleared
chromatin was immunoprecipitated with 45 mg of an anti-BMAL1
antibody (sc-48790x) or not (no antibody control) with subsequent
addition of 400 ml of a 50% slurry of salmon sperm DNA/protein
A beads for 3 hrs at 4uC. The ChIP-on-chip target genes were
classified by biological function based on GO annotation (http://
fatigo.org/) and NCBI gene descriptions. The mouse liver BMAL1
ChIP-on-chip bed file can be found in Dataset S1.
Ingenuity pathway analysis of target genes
Analysis of the ChIP-on-chip target genes for significant
biological pathways and networks were done using Ingenuity
Pathways Analysis software v7.6 (IngenuitySystems, www.ingenuity.
com). Canonical pathways analysis identified significant pathways
from the Ingenuity’s Pathways Analysis library of canonical
pathways. Fisher’s exact test was used to calculate a p-value
determining the probabilitythat the association between thegenesin
a dataset and the canonical pathway is explained by chance alone.
Networks of genes were algorithmically generated based on their
connectivity by overlaying the target genes onto a global molecular
network developed from information contained in the Ingenuity
Pathways Knowledge Base.
Constructs
pCMX, pCMX-hERRa and mESRRA-luciferase were de-
scribed previously [29]. The expression vector pcDNA3/HA-
hPGC-1a was provided by A. Kralli (La Jolla, CA). The expression
vectors pSG5-mCLOCK and pCS2 (56 Myc)-mBMAL1 were
described previously [59].
Reporter assays
Cos-1orHepG2cellsweretransfectedusingFUGENEin12-well
plates with 300 ng luciferase reporter, 100 ng CMX expression
vector (empty vector or hERRa), 100 ng CMV b-galactosidase,
200 ng pSG5 expression vector (empty vector or mCLOCK),
200 ng pCS2 (56 myc) expression vector (empty vector or
mBMAL1), with 300 ng of HA-PGC1a or pcDNA3. Cells were
harvested and assayed for luciferase activity 24 hrs post-transfec-
tion.Experimentswere performedintriplicateandeachexperiment
was replicated multiple times.
RNA interference
HepG2 cells were cultured in DMEM (Invitrogen) supplemented
with 10% FBS and pen/strep and maintained at 70% confluency.
HepG2 were transfected with either On-Target Smartpool control
(siCtrl) from Dharmacon or a specific siRNA pool against PROX1
(siProx1) using HiPerfect reagent (according to the manufacturer’s
instructions).
Serum shock
HepG2 cells treated with either control siRNA (siCtrl) or siProx1
were grown and maintained in high glucose (25 mM) Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 10% fetal
bovine serum (FBS). 48 hrs later, the cells were then starved in
DMEM containing 0.5% fetal bovine serum for 24 hrs. Subse-
quently, 50% horse serum was added (T=0) for 2 hrs, and then the
mediumwaschanged backtostarvationmedium.RNAwasisolated
from cells harvested every 4 hrs during a 24 hr period for qRT-
PCR analysis.
Quantitative reverse-transcription PCR
For quantitative reverse-transcription PCR, cDNA was prepared
from total RNA isolated from mouse livers and the HepG2 siRNA
knock-down samples. cDNA was obtained from 2 mg of total RNA
by reverse transcription with Oligo(dT) primer, dNTPs, 56 1
st
strand buffer, DTT, RNase inhibitor, and Superscript II RNase H
Reverse Transcriptase. cDNA was amplified using specific primers
(Tables S6 and S7) along withthe SYBR PCR Master Mix (Qiagen)
and a LightCycler instrument (Roche). Relative fold expression
levels of the analyzed genes in mouse livers were normalized to Arbp
levels and expressed as mean values +/2 SEM at the indicated time
points relative to the mean value of the WT livers at ZT 4 set at 1.
For all genes tested, primer efficiencies were taken into account
based on a serial dilution of cDNA.
Relative fold expression levels of the analyzed genes in serum
shocked HepG2 cells were normalized to HPRT1 levels and
expressed as mean values +/2 s.d. at the indicated time points
relative to the mean value of siCtrl samples at T=0 set at 1. For all
genes tested, primer efficiencies were taken into account based on
a serial dilution of cDNA.
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livers using the Qiagen miRNeasy kit. microRNA levels were
detected and normalized to snoRNA412 levels using Taqman
miRNA RT-PCR following the manufacturer’s instructions
(Applied Biosystems, snoRNA412 #1243, miR-122a #2245,
miR-378* #567). Real-Time PCR reactions were carried out in
a Corbett Research Rotor-Gene instrument.
Western blot analysis
Nuclear extracts were prepared from livers of WT and ERRa-
null mice collected during a 12:12 h LD schedule. Briefly, the
livers were homogenized in cell lysis buffer (HEPES 5 mM, KCl
85 mM, NP40 0.5%) containing protease and phosphatase
inhibitor cocktails (Roche) and the nuclei collected were prepared
in lysis buffer (sodium phosphate 20 mM, NaCl 150 mM, NP40
1%, EDTA 5 mM, PMSF 1 mM) containing protease and
phosphatase inhibitor cocktails (Roche). Equal amounts of protein
were pooled from 4 WT and 4 ERRa-null liver nuclear extracts at
the indicated time points and a total of 20 mg protein extract at
each time point were used for immunoblot analysis. Immunoblot
detection was done using a custom made anti-ERRa (1:10,000)
antibody [29], anti-BMAL1 (Santa Cruz, sc-8550X, 1:1,000) and
anti-CLOCK (Santa Cruz, sc-6927X, 1:1,000) antibodies.
Whole cells lysates from the HepG2 knock-down samples were
prepared in lysis buffer (sodium phosphate 20 mM, NaCl
150 mM, NP40 1%, EDTA 5 mM, PMSF 1 mM) containing
protease and phosphatase inhibitor cocktails (Roche). 50 ug of
total protein lysate was used for immunoblot analysis. Immunoblot
detection was done using anti-PROX1 (Proteintech Group,
51043-1-AP, 1:400) antibody and anti-RPLP (Proteintech Group,
11290-2-AP, 1:2,000) antibody was used as a loading control.
Locomotor activity in running wheels
Wheel-running activity data were collected from male adult age-
matched WT (n=9) and ERRa-null (n=10) mice. Animals were
put in running wheel cages (Actimetrics, Wilmette, IL, USA) set in
a light-proof ventilated cabinet. Activity under a 12 hr light
(,200 lux), 12 hr dark cycle (LD) was recorded over 5 days
following entrainment of the animals to this schedule. Animals
were then kept in DD conditions for 20 days and the recordings of
day 3 to day 20 in DD were used for defining circadian parameters
in free running conditions. All data were analyzed using the
Clocklab program (Actimetrics, Wilmette, IL, USA). Chi
2 period-
ogram analysis was used for measurement of the free-running
period.
Metabolic measurements
Serum metabolic measurements of insulin, bile acid, total
cholesterol, NEFA and triglycerides were conducted on male WT
and ERRa knock-out mice (n=4) under basal (fed ad libitum) and
fasted conditions. For fasting experiments, mice were housed in
cages with woodchip bedding instead of corncob bedding and food
was removed from cages 24 hrs prior to the start of blood
collection every 4 hrs during a 24 hr period. Blood was isolated by
cardiac puncture from mice anesthetized with isofluorene gas.
Blood was allowed to clot for 45 min in serum separation tubes
(Sarstedt, 41.1378.005) with subsequent centrifugation at
5000 rpm for 30 min. Serum was isolated and stored at 280uC
until further processing. Total cholesterol, triglyceride, bile acid
and NEFA levels were detected by enzymatic colorimetric rate
assays performed at IDEXX Laboratories (Markham, Ontario).
Specifically, cholesterol CHOD-PAP (Roche), triglyceride GPO-
PAP (Roche), total bile acids assay (Diazyme) and VetSpec NEFA
(Catachem Inc.) kits were used and samples were run on a Roche
Hitachi H917 chemistry analyzer. Radioimmunoassay detection of
insulin with rat insulin RIA kits (Millipore) was performed at the
Animal Health Diagnostic Center at Cornell University.
Blood glucose levels were measured using a OneTouch Ultra2
glucose meter (LifeScan) on male WT and ERRa knock-out mice.
For glucose tolerance tests, mice were housed in cages with
woodchip bedding and fasted for 6 hrs prior to intraperitoneal
injection of a 20% glucose solution in 0.9% NaCl at 2 mg/g of
body weight. Glucose levels were measured prior to glucose
administration and at the indicated time points post-injection.
Supporting Information
Figure S1 Circadian expression of genes involved in transcrip-
tional regulation (A), glycolysis/gluconeogesesis (B) and the TCA
cycle and Oxphos (C). Male WT and ERRa-null mice (n=4) kept
in LD conditions were sacrificed at 4 hr intervals over a 24 hr
period from ZT 4 to ZT 24. qRT-PCR analysis was performed on
RNA isolated from mouse livers and relative expression data
normalized to Arbp levels are shown as a function of ZT. Data
shown are relative to WT expression levels at ZT 4 arbitrarily set
to 1. ZT 0 values are a duplicate of ZT 24 shown for clarity. Error
bars represent 6 SEM. Student’s t test was used to compare WT
and ERRa KO liver expression data at the indicated time points,
*P,0.05.
(PDF)
Figure S2 Binding profiles of BMAL1 on extended promoters of
a subset of clock gene targets obtained from ChIP-on-chip.
Putative BMAL1/CLOCK binding sequences (E-boxes) are
shown.
(PDF)
Figure S3 Mouse liver ERRa and BMAL1 standard ChIP
assays on shared ChIP-on-chip target genes involved in AMPK
signaling, glycolysis/gluconeogenesis and insulin receptor signal-
ing.
(PDF)
Figure S4 HepG2 cells treated with either control siRNA (siCtrl)
or siRNA against Prox1 were grown in DMEM containing 10%
fetal bovine serum (FBS) for 48 hrs then starved in DMEM
containing 0.5% fetal bovine serum for 24 hrs. On the day of
serum shock, 50% horse serum was added (T=0) for 2 hrs, and
then the medium was changed back to starvation medium. Cells
were harvested every 4 hrs during a 24 hr period for total RNA
extraction. qRT-PCR analysis of molecular clock genes (A) and
involved in glucose homeostasis (B) was performed and relative
expression data normalized to Hprt1 levels are shown as a function
of time. Data shown are relative to siCtrl expression levels at T=0
arbitrarily set to 1. Error bars represent 6 SEM. Student’s t test
was used to compare siCtrl and siProx1 expression data at the
indicated time points, *P,0.05.
(PDF)
Figure S5 Venn Diagram illustrating the overlap in ERRa,
PROX1, and BMAL1 ChIP-on-chip target genes known to
display circadian rhythmic expression profiles under basal
conditions in mouse liver.
(PDF)
Table S1 Mouse liver BMAL1 enriched ChIP-on-chip target
genes.
(XLS)
Table S2 Comparison of mouse liver ERRa, PROX1 and
BMAL1 enriched ChIP-on-chip target genes.
(XLS)
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BMAL1 enriched ChIP-on-chip target genes with genes previously
known to display hepatic circadian rhythms.
(XLS)
Table S4 Mouse primers used for ERRa/PROX1 ChIP
quantitative PCR analysis.
(PDF)
Table S5 Mouse primers used for BMAL1/CLOCK ChIP
quantitative PCR analysis.
(PDF)
Table S6 Mouse primers used for qRT-PCR.
(PDF)
Table S7 Human primers used for qRT-PCR.
(PDF)
Dataset S1 Mouse liver BMAL1 ChIP-on-chip enriched
binding events in BED format which can be loaded into the
UCSC mm8 genome browser.
(TXT)
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